Seeking an AACT Representative to the Scientific Liaison Coalition
About the SLC The mission of the Scientific Liaison Coalition (SLC) is to improve and enhance human and environmental health by promoting and strengthening scientific partnerships between clinical and...
View ArticleClik here to view.
Mark Thoman, MD, FAAP, FAACT, FACMT 1936-2022
Mark Thoman, MD, passed away in Tucson, Arizona, on September 15th, just as NACCT was getting underway in San Francisco. This is a memorable description of Mark’s dedicated lifetime as a pediatrician...
View ArticleSave the Date for AACT Symposium: DEI in Toxicology
AACT is excited to announce a half-day symposium at the ACMT annual meeting. 2023 AACT Symposium | DEI in Toxicology: What it Means for Patients and Learners Wednesday, March 29, 2023 12:45 pm – 5:15...
View ArticleTOXISMO Article 1-17-23
1995- AEM- Liebelt- ECG aVR in TCA OD The post TOXISMO Article 1-17-23 appeared first on The American Academy of Clinical Toxicology.
View ArticleSign up for NACCT Updates
Make sure you don’t miss a thing! Sign up to receive NACCT 2023 emails and announcements by clicking the button below. Also make sure that nacct@clintox.org is marked safe and not going into your spam...
View ArticleNACCT 2023 Abstract Submissions -Submit Yours Today
NACCT 2023 Abstract Submissions The post NACCT 2023 Abstract Submissions -Submit Yours Today appeared first on The American Academy of Clinical Toxicology.
View ArticleAnnouncing ToxLab, a New & Exciting Symposia Format at NACCT
Introducing ToxLab! Education is one of the primary missions of the American Academy of Clinical Toxicology. We strive to be innovators in education as well as scientific excellence. AACT is excited to...
View ArticleSeeking Nominees for 2023 AACT National Election
We are seeking nominations for key leadership positions within the AACT. The applications of prospective nominees will be reviewed and a final ballot will be assembled by the AACT Board of Trustees....
View ArticleAACT Antidote Collective
The newly formed AACT Antidote Collective is currently underway in planning subcommittees to address various aspects related to antidote and medication shortages. The efforts of these subcommittees...
View ArticleACMT & AACT Joint Position Statement on Nalmefene
Nalmefene should not replace naloxone as the primary opioid antidote at this time. Read the entire statement here. The post ACMT & AACT Joint Position Statement on Nalmefene appeared first on The...
View Article
